Are Options Traders Bullish on ADRO?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ADRO

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduros lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADRO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 294.9 M 2.94941E+08 202 202 0.02% 0.000160454 99 K 98611
EQWS Invesco Russell 2000 Equal Weight ETF 21.1 M 2.11E+07 1,979 1979 0.02% 0.00016 3 K 3458
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 347 347 0.0% 3.21339E-05 50 K 49780
IBB iShares Nasdaq Biotechnology Index Fund 8.1 B 8.0755E+09 191 191 0.04% 0.0004 3.0 M 3006480
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.5 B 1.554E+10 3,423 3423 0.0% 0 47 K 47033
IWM iShares Russell 2000 ETF 44.6 B 4.46355E+10 2,024 2024 0.01% 0.0001 4.7 M 4687560
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28799E+09 1,241 1241 0.02% 0.0002 2.0 M 1953070
IWV iShares Russell 3000 ETF 8.4 B 8.42237E+09 3,007 3007 0.0% 0 73 K 72784
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.8 B 1.8E+09 1,029 1029 0.0% 2.51916E-05 45 K 45128
SBIO ALPS Medical Breakthroughs ETF 226.2 M 2.26151E+08 112 112 0.19% 0.0019 430 K 429687
UBIO Proshares UltraPro Nasdaq Biotechnology 30.1 M 3.01163E+07 196 196 0.01% 7.39178E-05 7 K 7409
URTY ProShares UltraPro Russell2000 115.1 M 1.15088E+08 2,034 2034 0.0% 1.8374E-05 7 K 7192
UWM ProShares Ultra Russell2000 165.6 M 1.65571E+08 2,034 2034 0.0% 4.2227E-05 15 K 14927

Wait, Before You Leave...